The Hepatitis C Trust has raised "profound concerns" about the payouts for those who underwent the "unethical research" by ...

The Hepatitis C Trust has raised concerns about an element of the payouts for people who were victims of “unethical research” ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

A controversial Hepatitis B vaccine safety trial will go on as planned in Africa, amid concerns over its ethics and design ...

Texas Biomed researchers find that existing treatments control TB and HIV, but the immune system does not revert to normal, ...

MANILA – Members of the Philippine Health Insurance Corporation (PhilHealth) can avail of benefit packages of up to PHP24,765 ...

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Federal health officials upended the immunization schedule for American children this week. These are the diseases affected.

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Atea Pharmaceuticals offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines the advantages of current first-line HCV therapies—single pill ...

Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...

Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...